Clinical Trial Update: Evaluate the Efficacy of Sorafenib in Renal Cell Carcinoma Patients After a Radical Resection of the Metastases [Phase 2]

View source ↗

Summary

A Phase 2 trial evaluating sorafenib efficacy in renal cell carcinoma patients after radical resection of metastases is in development, with status not specifie…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Renal Cell Carcinoma

Drugs mentioned

• Sorafenib (Sorafenib)

Snippet

Sponsor: Fondazione IRCCS Istituto Nazionale dei Tumori, Milano | Conditions: Metastatic Renal Cell Carcinoma | Phase 2 | Status: UNKNOWN